Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference.
living donor liver transplant
living donor transplant recipient
living liver donor
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
14
02
2023
received:
28
12
2022
accepted:
25
02
2023
medline:
14
7
2023
pubmed:
10
3
2023
entrez:
9
3
2023
Statut:
ppublish
Résumé
Living donor liver transplantation (LDLT) is a promising option for mitigating the deceased donor organ shortage and reducing waitlist mortality. Despite excellent outcomes and data supporting expanding candidate indications for LDLT, broader uptake throughout the United States has yet to occur. In response to this, the American Society of Transplantation hosted a virtual consensus conference (October 18-19, 2021), bringing together relevant experts with the aim of identifying barriers to broader implementation and making recommendations regarding strategies to address these barriers. In this report, we summarize the findings relevant to the selection and engagement of both the LDLT candidate and living donor. Utilizing a modified Delphi approach, barrier and strategy statements were developed, refined, and voted on for overall barrier importance and potential impact and feasibility of the strategy to address said barrier. Barriers identified fell into three general categories: 1) awareness, acceptance, and engagement across patients (potential candidates and donors), providers, and institutions, 2) data gaps and lack of standardization in candidate and donor selection, and 3) data gaps regarding post-living liver donation outcomes and resource needs. Strategies to address barriers included efforts toward education and engagement across populations, rigorous and collaborative research, and institutional commitment and resources.
Types de publication
Consensus Development Conference
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14954Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015;150:252-259.
Yang LS, Shan LL, Saxena A, Morris DL. Liver transplantation: a systematic review of long-term quality of life. Liver Int. 2014;34:1298-1313.
Kardashian A, Ge J, McCulloch CE, et al. Identifying an optimal liver frailty index cutoff to predict waitlist mortality in liver transplant candidates. Hepatology. 2021;73:1132-1139.
Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564-574.
Cullaro G, Sarkar M, Lai JC. Sex-based disparities in delisting for being “too sick” for liver transplantation. Am J Transplant. 2018;18:1214-1219.
Ross K, Patzer RE, Goldberg DS, Lynch RJ. Sociodemographic determinants of waitlist and posttransplant survival among end-stage liver disease patients. Am J Transplant. 2017;17:2879-2889.
Brige P, Hery G, Chopinet S, Palen A, Azoulay D, Gregoire E. Morbidity and mortality of hepatic right lobe living donors: systematic review and perspectives. J Gastrointestin Liver Dis. 2018;27:169-178.
Lei J, Yan L, Wang W. Donor safety in living donor liver transplantation: a single-center analysis of 300 cases. PLoS One. 2013;8:e61769.
Pamecha V, Mahansaria SS, Bharathy KG, et al. Selection and outcome of the potential live liver donor. Hepatol Int. 2016;10:657-664.
Abu-Gazala S, Olthoff KM. Current status of living donor liver transplantation in the United States. Annu Rev Med. 2019;70:225-238.
Park JJ, Kim K, Choi JY, Shim SR, Kim JH. Long-term mortality of living kidney donors: a systematic review and meta-analysis. Int Urol Nephrol. 2021;53:1563-1581.
Vargas PA, McCracken EKE, Mallawaarachchi I, et al. Donor morbidity Is equivalent between right and left hepatectomy for living liver donation: a meta-analysis. Liver Transpl. 2021;27:1412-1423.
LaPointe Rudow D, DeLair S, Feeley T, et al. Longterm impact of living liver donation: a self-report of the donation experience. Liver Transpl. 2019;25:724-733.
Kling CE, Perkins JD, Reyes JD, Montenovo MI. Living donation versus donation after circulatory death liver transplantation for low model for end-stage liver disease recipients. Liver Transpl. 2019;25:580-587.
Goldberg DS, French B, Abt PL, Olthoff K, Shaked A. Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology. 2014;60:1717-1726.
Berg CL, Merion RM, Shearon TH, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011;54:1313-1321.
Rela M, Rammohan A. Why are there so many liver transplants from living donors in Asia and so few in Europe and the US? J Hepatol. 2021;75:975-980.
Gill JS, Schold J, Kaplan B. Understanding risks and our responsibility to living donors. J Am Soc Nephrol. 2021;32:2691-2693.
Liapakis A, Jesse MT, Pillai A, et al. Living donor liver transplantation: a multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clin Transplant
Yadav SK, Saraf N, Choudhary NS, et al. Living Donor liver transplantation for acute-on-chronic liver failure. Liver Transpl. 2019;25:459-468.
Doyle A, Rabie RN, Mokhtari A, et al. Recipient factors associated with having a potential living donor for liver transplantation. Liver Transpl. 2015;21:897-903.
Barbetta A, Butler C, Barhouma S, et al. Living donor versus deceased donor pediatric liver transplantation: a systematic review and meta-analysis. Transplant Direct. 2021;7:e767.
AST Living Donor Liver Transplant Provider Toolkit Accessed March 14, 2023. https://www.myast.org/education/specialty-resources/living-donor-provider-toolkits
Nobel YR, Forde KA, Wood L, et al. Racial and ethnic disparities in access to and utilization of living donor liver transplants. Liver Transpl. 2015;21:904-913.
Hoehn RS, Wilson GC, Wima K, et al. Comparing living donor and deceased donor liver transplantation: a matched national analysis from 2007 to 2012. Liver Transpl. 2014;20:1347-1355.
Barnieh L, Collister D, Manns B, et al. A scoping review for strategies to increase living kidney donation. Clin J Am Soc Nephrol. 2017;12:1518-1527.
Hunt HF, Rodrigue JR, Dew MA, et al. Strategies for increasing knowledge, communication, and access to living donor transplantation: an evidence review to inform patient education. Curr Transplant Rep. 2018;5:27-44.
Delair S, Feeley TH, Kim H, et al. A peer-based intervention to educate liver transplant candidates about living donor liver transplantation. Liver Transpl. 2010;16:42-48.
Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25-30.
Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408-1421.
Goldaracena N, Gorgen A, Doyle A, et al. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. J Hepatol. 2019;70:666-673.
Mazumder NR, Celaj S, Atiemo K, et al. Liver-related mortality is similar among men and women with cirrhosis. J Hepatol. 2020;73:1072-1081.
Chang CH, Bryce CL, Shneider BL, et al. Accuracy of the pediatric end-stage liver disease score in estimating pretransplant mortality among pediatric liver transplant candidates. JAMA Pediatr. 2018;172:1070-1077.
D'Amico G, Morabito A, D'Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563-576.
Lai JC, Rahimi RS, Verna EC, et al. Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study. Gastroenterology. 2019;156:1675-1682.
Atiemo K, Skaro A, Maddur H, et al. Mortality risk factors among patients with cirrhosis and a low model for end-stage liver disease sodium score (≤15): an analysis of liver transplant allocation policy using aggregated electronic health record data. Am J Transplant. 2017;17:2410-2419.
Bonney GK, Chew CA, Lodge P, et al. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol. 2021;6:933-946.
Hibi T, Rela M, Eason JD, et al. Liver transplantation for colorectal and neuroendocrine liver metastases and hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus conference. Transplantation. 2020;104:1131-1135.
Sapisochin G, Javle M, Lerut J, et al. Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus conference. Transplantation. 2020;104:1125-1130.
Emamaullee J, Conrad C, Kim M, et al. Assessment of the global practice of living donor liver transplantation. Transpl Int. 2021;34:1914-1927.
Soin AS, Chaudhary RJ, Pahari H, Pomfret EA. A worldwide survey of live liver donor selection policies at 24 centers with a combined experience of 19 009 adult living donor liver transplants. Transplantation. 2019;103:e39-e47.
Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the united states, national health and nutrition examination survey, 1988-2012. Prev Chronic Dis. 2017;14:E24.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief, no 360. Hyattsville, MD: National Center for Health Statistics. 2020.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73-84.
Knaak M, Goldaracena N, Doyle A, et al. Donor BMI >30 is not a contraindication for live liver donation. Am J Transplant. 2017;17:754-760.
Mendes-Braz M, Martins JO. Diabetes mellitus and liver surgery: the effect of diabetes on oxidative stress and inflammation. Mediators Inflamm. 2018;2018:2456579.
Kasiske BL, Ahn YS, Conboy M, et al. Outcomes of living liver donor candidate evaluations in the living donor collective pilot registry. Clin Transplant. 2021;35:e14394.
Dew MA, Zuckoff A, DiMartini AF, et al. Prevention of poor psychosocial outcomes in living organ donors: from description to theory-driven intervention development and initial feasibility testing. Prog Transplant. 2012;22:280-292; quiz 293.
Ogawa H, Fujimoto Y, Yamamoto K, et al. Donor screening algorithm for exclusion of thrombophilia during evaluation of living donor liver transplantation. Clin Transplant. 2011;25:277-282.
Kamei H, Onishi Y, Kurata N, Ishigami M, Ogura Y. Donor selection and prophylactic strategy for venous thromboembolic events in living donors of liver transplantation based on results of thrombophilia screening tests. Ann Transplant. 2017;22:409-416.
Doshi SD, Wood L, Abt PL, et al. Outcomes of living-donor liver transplantation using grafts heterozygous for alpha-1 antitrypsin gene mutations. Transplantation. 2019;103:1175-1180.
Shaked O, Gonzalez A, Bahirwani R, et al. Donor hemosiderosis does not affect liver function and regeneration in the setting of living donor liver transplantation. Am J Transplant. 2014;14:216-220.
DiMartini A, Dew MA, Liu Q, et al. Social and financial outcomes of living liver donation: a prospective investigation within the adult-to-adult living donor liver transplantation cohort study 2 (A2ALL-2). Am J Transplant. 2017;17:1081-1096.
Mathur AK, Stewart Lewis ZA, Warren PH, et al. Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors. Am J Transplant. 2020;20:25-33.
Shield D. Donor Protections. Accessed October 10, 2021. https://www.donor-shield.org/donor-protections/
Butt Z, Dew MA, Liu Q, et al. Psychological outcomes of living liver donors from a multicenter prospective study: results from the adult-to-adult living donor liver transplantation cohort study2 (A2ALL-2). Am J Transplant. 2017;17:1267-1277.